Summary of Key Information:

BSE Scrip: 532271

NSE Scrip: ORCHASP

Announcement Date: August 31, 2026

Nature of Security Issuance: Equity Shares

Mode of Issuance: Preferential allotment

Total Issue Size: 1,50,00,000 (One Crore Fifty Lakhs) Equity Shares

Listing Exchange: BSE Limited and National Stock Exchange of India Limited

Form of Allotment: Preferential basis

Security Type: Equity Shares of Face value of Rs. 2/- each

Deemed Date of Allotment: Not specified (Subject to shareholder approval)

Financial Impact of the Issuance:

Issue Price per Security: Rs. 4.74 per equity share (including a premium of Rs. 2.74 per share)

Total Proceeds Expected: Rs. 7,11,00,000/- (Rupees Seven Crores Eleven Lakhs Only)

Impact on Shareholding Structure: Post-preferential issue shareholding of allottee will be 4.15% (corrected from previously reported 2.12%)

Expected Use of Proceeds: Conversion of loan due to Wahtulmsylh Limgawlat (Promoter Group entity)

Strategic Insights:

Rationale for the Issuance: To convert loan due to promoter group entity Wahtulmsylh Limgawlat (C.R. No. 105596) into equity shares

Other Noteworthy Information:

  • The revision is solely to correct a typographical error in the percentage of post-preferential issue shareholding from 2.12% to 4.15%
  • The Relevant Date for the preferential issue is Friday, August 28, 2026 (30 days prior to shareholder meeting)
  • Approval subject to shareholder approval at the ensuing Annual General Meeting
  • The board meeting was held on August 31, 2026 from 1:00 PM to 3:45 PM
  • Annual General Meeting scheduled for Wednesday, September 30, 2026 through audio-video conferencing mode

Director Appointments:

The Board also approved the appointment of:

1. Mrs. Sirisha Pattapurathi (DIN: 02185189) as Non-Executive, Non-Independent Director (holds 1100 equity shares, related to Mr. Chandra Sekhar Pattapurathi)

2. Mr. Srinivasu Sunkara (DIN: 11509166) as Independent Director for 5 years (February 10, 2026 to February 09, 2031)

3. Mr. Ravi Prasad Muthyam (DIN: 06603818) as Independent Director for 5 years (March 6, 2026 to March 5, 2031)

All director appointments are subject to shareholder approval at the Annual General Meeting.